Cargando…

Semi-quantitative MRI biomarkers of knee osteoarthritis progression in the FNIH biomarkers consortium cohort − Methodologic aspects and definition of change

BACKGROUND: To describe the scoring methodology and MRI assessments used to evaluate the cross-sectional features observed in cases and controls, to define change over time for different MRI features, and to report the extent of changes over a 24-month period in the Foundation for National Institute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roemer, Frank W., Guermazi, Ali, Collins, Jamie E., Losina, Elena, Nevitt, Michael C., Lynch, John A., Katz, Jeffrey N., Kwoh, C. Kent, Kraus, Virginia B., Hunter, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105263/ https://www.ncbi.nlm.nih.gov/pubmed/27832771 http://dx.doi.org/10.1186/s12891-016-1310-6

Ejemplares similares

Biomarkers in osteoarthritis: current status and outlook — the FNIH Biomarkers Consortium PROGRESS OA study
por: Hunter, David J., et al.
Publicado: (2023)

Association of quantitative measures of effusion-synovitis and hoffa-synovitis with radiographic and pain progression: Data from the FNIH OA biomarkers consortium
por: Smith, Stacy E., et al.
Publicado: (2021)

Patterns of progression differ between Kellgren-Lawrence 2 and 3 knees fulfilling different definitions of a cartilage-meniscus phenotype in the Foundation for National Institutes of Health Osteoarthritis Biomarkers study (FNIH)
por: Roemer, Frank W., et al.
Publicado: (2022)

Development and evaluation of nomograms for predicting osteoarthritis progression based on MRI cartilage parameters: data from the FNIH OA biomarkers Consortium
por: Deng, Chunbo, et al.
Publicado: (2023)

Novel nomogram for predicting the progression of osteoarthritis based on 3D-MRI bone shape: data from the FNIH OA biomarkers consortium
por: Sun, Yingwei, et al.
Publicado: (2021)

DETERMINING THE PREVALENCE OF SARCOPENIA IN AN INPATIENT GERIATRIC POPULATION USING EWGSOP2 OR FNIH DEFINITIONS
por: Scholl, Matthew M, et al.
Publicado: (2019)

Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition
por: Dietzel, Roswitha, et al.
Publicado: (2022)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

Structural phenotypes of knee osteoarthritis: potential clinical and research relevance
por: Roemer, Frank W., et al.
Publicado: (2022)

The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates
por: Studenski, Stephanie A., et al.
Publicado: (2014)

MR Imaging-based Semi-quantitative Methods for Knee Osteoarthritis
por: JARRAYA, Mohamed, et al.
Publicado: (2015)

Longitudinal assessment of cyst-like lesions of the knee and their relation to radiographic osteoarthritis and MRI-detected effusion and synovitis in patients with knee pain
por: Hayashi, Daichi, et al.
Publicado: (2010)

Worsening of Articular Tissue Damage as Defined by Semi-Quantitative MRI Is Associated With Concurrent Quantitative Cartilage Loss Over 24 Months
por: Roemer, Frank, et al.
Publicado: (2023)

Semiquantitative assessment of subchondral bone marrow edema-like lesions and subchondral cysts of the knee at 3T MRI: A comparison between intermediate-weighted fat-suppressed spin echo and Dual Echo Steady State sequences
por: Hayashi, Daichi, et al.
Publicado: (2011)

Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH‐ASBMR SABRE Project
por: Eastell, Richard, et al.
Publicado: (2021)

Structural tissue damage and 24-month progression of semi-quantitative MRI biomarkers of knee osteoarthritis in the IMI-APPROACH cohort
por: Roemer, Frank W., et al.
Publicado: (2022)

Biomarker Acquisition and Quality Control for Multi-Site Studies: The Autism Biomarkers Consortium for Clinical Trials
por: Webb, Sara Jane, et al.
Publicado: (2020)

Unmet need for liquid biomarkers and the Brain-Liquid Biopsy Consortium
por: Short, Susan C, et al.
Publicado: (2022)

Biomarkers: A Definite Plus in Pneumonia
por: Summah, Hanssa, et al.
Publicado: (2009)

Biomarkers in Inflammatory Myopathies—An Expanded Definition
por: Benveniste, Olivier, et al.
Publicado: (2019)

Cross-sectional and longitudinal reliability of semiquantitative osteoarthritis assessment at 1.0T extremity MRI: Multi-reader data from the MOST study
por: Crema, Michel D., et al.
Publicado: (2021)

Analyzing Illumina Gene Expression Microarray Data from Different Tissues: Methodological Aspects of Data Analysis in the MetaXpress Consortium
por: Schurmann, Claudia, et al.
Publicado: (2012)

Prevalence of MRI-detected mediopatellar plica in subjects with knee pain and the association with MRI-detected patellofemoral cartilage damage and bone marrow lesions: data from the Joints On Glucosamine study
por: Hayashi, Daichi, et al.
Publicado: (2013)

Criteria for Clinically Relevant Weakness and Low Lean Mass and Their Longitudinal Association With Incident Mobility Impairment and Mortality: The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project
por: McLean, Robert R., et al.
Publicado: (2014)

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update
por: Boccardi, Marina, et al.
Publicado: (2021)

Higher thyroid hormone has a negative association with lower limb lean body mass in euthyroid older adults: Analysis from the Baltimore Longitudinal study of aging
por: Ibad, Hamza Ahmed, et al.
Publicado: (2023)

Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis
por: Ritter, Susan Y, et al.
Publicado: (2014)

The Autism Biomarkers Consortium for Clinical Trials (ABC-CT): Scientific Context, Study Design, and Progress Toward Biomarker Qualification
por: McPartland, James C., et al.
Publicado: (2020)

Evaluation of district mental healthcare plans: the PRIME consortium methodology
por: De Silva, Mary J., et al.
Publicado: (2016)

Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters
por: Bruin, Willem B., et al.
Publicado: (2020)

Sex‐Specific Influence of Quadriceps Weakness on Worsening Patellofemoral and Tibiofemoral Cartilage Damage: A Prospective Cohort Study
por: Culvenor, Adam G., et al.
Publicado: (2019)

The Autism Biomarkers Consortium for Clinical Trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials
por: Shic, Frederick, et al.
Publicado: (2022)

Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium
por: Weiner, January, et al.
Publicado: (2019)

COSMIC (Cohort Studies of Memory in an International Consortium): An international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethnic and sociocultural groups
por: Sachdev, Perminder S, et al.
Publicado: (2013)

Methodology for Constructing Problem Definitions in Bioinformatics
por: Hauth, Amy M., et al.
Publicado: (2008)

Rapid literature review: definition and methodology
por: Smela, Beata, et al.
Publicado: (2023)

Objective performance tests assess aspects of function not captured by self-report in knee osteoarthritis
por: Selzer, Faith, et al.
Publicado: (2022)

The Foundation for the National Institutes of Health Biomarkers Consortium: Past Accomplishments and New Strategic Direction
por: Menetski, Joseph P., et al.
Publicado: (2019)

MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortium
por: Maillard, Pauline, et al.
Publicado: (2022)

Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
por: Hahn, Rebecca T, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i1tbdmdlrp4mvr9kn9fe1t5tgc